Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL 35294-3360, United States.
Biochem Biophys Res Commun. 2013 Apr 19;433(4):567-72. doi: 10.1016/j.bbrc.2013.03.030. Epub 2013 Mar 21.
Overexpression of adiponectin receptor 1 in macrophages can physiologically modulate metabolic activities in vivo by enhancing adiponectin actions in distal metabolically active tissues. To investigate the effects of enhanced adiponectin actions in TALLYHO (TH) diabetic mouse model, we crossed the adiponectin receptor 1 macrophage-specific transgenic mice (AdR1-TG) with the TALLYHO diabetic mice (TH) to examine the changes of lipid accumulation and insulin sensitivity in these mice.
AdR1-TG/TH and the control WT/TH mice were fed either normal diet or high fat diet for 28weeks. Whole body weights of these mice were measured and mouse sera were analyzed for the levels of cholesterol, triglyceride, and free fatty acids. Glucose tolerance testing (GTT) and insulin tolerance testing (ITT) in these mice were performed to investigate systemic insulin sensitivity in vivo. Molecular markers for insulin signaling pathway in mouse skeletal muscle tissues, IRS-1 and AKT, were examined. Mouse serum insulin levels were measured and Sirt1 gene expression in mouse pancreatic tissues was also quantified related to the insulin secretion. The Caspase 3 protein levels were analyzed by Western blot methods.
Compared to the control WT/TH mice, AdR1-TG/TH mice showed significantly lower body weights under either normal diet or high fat diet and the mouse serum levels of cholesterol, triglyceride and free fatty acids were significantly decreased in the transgenic crossed mice when compared to those from the control mice. Improved GTT and ITT tests indicating increased systemic insulin sensitivity in the transgenic crossed mice demonstrated the enhanced adiponectin actions on the systemic metabolism in vivo. The increases of insulin secretion and its related gene expression were also detected in the transgenic crossed mice. In contrast, the control mice showed hypertrophy pancreases companying with high apoptosis gene expression. These results suggest that enhanced adiponectin actions by overexpressing adiponectin receptor 1 in macrophages can provide unique interactions with the metabolic tissues/cells, improving lipid accumulation and insulin sensitivity in TALLYHO diabetic mice.
在巨噬细胞中过表达脂联素受体 1 可以通过增强脂联素在远处代谢活跃组织中的作用来生理性地调节体内的代谢活性。为了研究增强 TALLYHO(TH)糖尿病小鼠模型中的脂联素作用的影响,我们将脂联素受体 1 巨噬细胞特异性转基因小鼠(AdR1-TG)与 TALLYHO 糖尿病小鼠(TH)杂交,以检查这些小鼠中脂质积累和胰岛素敏感性的变化。
AdR1-TG/TH 和对照 WT/TH 小鼠分别用正常饮食或高脂肪饮食喂养 28 周。测量这些小鼠的全身重量,并分析小鼠血清中的胆固醇、甘油三酯和游离脂肪酸水平。对这些小鼠进行葡萄糖耐量试验(GTT)和胰岛素耐量试验(ITT),以研究体内系统胰岛素敏感性。检查小鼠骨骼肌组织中的胰岛素信号通路分子标记物 IRS-1 和 AKT。测量小鼠血清胰岛素水平,并定量检测小鼠胰腺组织中的 Sirt1 基因表达与胰岛素分泌的关系。通过 Western blot 方法分析 Caspase 3 蛋白水平。
与对照 WT/TH 小鼠相比,在正常饮食或高脂肪饮食下,AdR1-TG/TH 小鼠的体重明显较低,与对照小鼠相比,转基因杂交小鼠的血清胆固醇、甘油三酯和游离脂肪酸水平明显降低。改善的 GTT 和 ITT 试验表明,转基因杂交小鼠的全身代谢中系统胰岛素敏感性增强。还检测到转基因杂交小鼠胰岛素分泌及其相关基因表达的增加。相比之下,对照小鼠表现出肥大的胰腺,同时伴随着高凋亡基因表达。这些结果表明,通过在巨噬细胞中过表达脂联素受体 1 增强脂联素作用可以与代谢组织/细胞提供独特的相互作用,改善 TALLYHO 糖尿病小鼠的脂质积累和胰岛素敏感性。